- Report
- August 2025
- 189 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- August 2025
- 187 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- August 2025
- 190 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- August 2025
- 185 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- January 2026
- 377 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 383 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 172 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 194 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 336 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 277 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 481 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 266 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 274 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 573 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 474 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 285 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 390 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 278 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 220 Pages
Global
From €5204EUR$5,850USD£4,515GBP
- Report
- January 2026
- 485 Pages
Global
From €5204EUR$5,850USD£4,515GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more